Cafepharma Today

November 1 2024 - Novo, with new results, to seek approval for obesity drug in MASH
Novo, with new results, to seek approval for obesity drug in MASH
FDA reconsiders CAR-T boxed warning on secondary cancers
Drug pricing and the 2024 presidential election
Lexicon's type 1 diabetes drug voted down by FDA adcomm
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Weight loss gold rush: Developers vie for next blockbuster treatment
Pharmaphorum
Tuesday, October 8, 2024 - 9:45am
tags:
R&D, obesity, weight loss, Novo Nordisk, Eli Lilly, Roche, Boehringer Ingelheim
Astellas places $2bn+ bet on AviadoBio dementia gene therapy
Pharmaphorum
Tuesday, October 8, 2024 - 9:44am
tags:
Astellas, gene therapy, AviadoBio, frontotemporal dementia
J&J discontinues late-stage study for bladder cancer drug
Reuters
Monday, October 7, 2024 - 10:01pm
tags:
JNJ, bladder cancer, clinical trials, TAR-200
CAMP4 is latest biotech to eye IPO, while Upstream spells out $182M plans
Fierce Biotech
Monday, October 7, 2024 - 9:58pm
tags:
CAMP4 Therapeutics, IPOs, Upstream Bio, RNA
Amid GLP-1 craze, Novo and Mylan ink patent settlement in Ozempic case
Fierce Pharma
Monday, October 7, 2024 - 9:56pm
tags:
Mylan Labs, Natco, Novo Nordisk, Ozempic, generics, patents, legal
Exact Sciences wins FDA approval for Cologuard Plus colorectal cancer test
Medtech Dive
Monday, October 7, 2024 - 9:54pm
tags:
undefined
Skyrizi notches top pharma, Rx brand spot for Q3 2024
Medical Marketing and Media
Monday, October 7, 2024 - 9:52pm
tags:
AbbVie, Skyrizi, Crohn's Disease, psoriatic arthritis
AstraZeneca heads to regulators after Airsupra asthma trial stops early thanks to 'overwhelming efficacy'
Fierce Pharma
Monday, October 7, 2024 - 9:50pm
tags:
AstraZeneca, Airsupra, asthma
GSK’s ViiV to expand supply of HIV drug in Africa
BioPharma Dive
Monday, October 7, 2024 - 9:47pm
tags:
GSK, ViiV Healthcare, HUV, PrEP, Africa
Pfizer wins bid to invalidate GSK's patents over RSV vaccine
Reuters
Monday, October 7, 2024 - 11:53am
tags:
Pfizer, GSK, patents, RSV, vaccines
Scholar Rock scores with ‘surprise’ success in SMA drug study
BioPharma Dive
Monday, October 7, 2024 - 11:52am
tags:
Scholar Rock, SMA, spinal muscular atrophy, apitegromab, obesity
Hospitals face IV shortages driven by hurricane
Axios
Monday, October 7, 2024 - 11:41am
tags:
hospitals, hurricane, North Carolina, IVs, Medtech, Baxter International
AstraZeneca to license CSPC Pharmaceutical’s lipid-lowering therapy
Pharmaceutical Business Review
Monday, October 7, 2024 - 11:38am
tags:
AstraZeneca, CSPC Pharmaceutical, lipids, YS2302018
Galecto buys leukemia drug from Bridge Medicines, drops bone cancer asset in strategic pivot
Fierce Biotech
Monday, October 7, 2024 - 11:36am
tags:
Galecto, oncology, liver disease, leukemia, Bridge Medicine
Activist investor Starboard Value takes $1 bln stake in Pfizer, sources say
Reuters
Monday, October 7, 2024 - 11:31am
tags:
Pfizer, activist investors, Starboard Value
FDA places hold on Kezar Life Sciences’ trial for lupus nephritis treatment
Clinical Trials Arena
Monday, October 7, 2024 - 11:29am
tags:
Kezar Life Sciences, lupus nephritis, FDA, zetomipzomib, clinical trials
Novo’s GLP-1 Wegovy could improve heart health for millions more than previously thought, AI study finds
Pharma Voice
Monday, October 7, 2024 - 11:23am
tags:
Novo Nordisk, Wegovy, cardiovascular disease, artificial intelligence, Dandelion Health
MicroRNA pioneers win Nobel Prize for medicine
Pharmaphorum
Monday, October 7, 2024 - 11:21am
tags:
Nobel Prize, microRNAQ, genetics
Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney
BioPharma Dive
Monday, October 7, 2024 - 11:18am
tags:
Jude Bio, RNA, ligand-siRNA, funding
For Bristol Myers Squibb's newly approved schizophrenia drug, what a long, strange trip it's been
Fierce Pharma
Monday, October 7, 2024 - 11:16am
tags:
Bristol Myers Squibb, KarXT, Cobenfy, schizophrenia

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

How Field Reimbursement Services Help Overcome Coverage Barriers and Improve Patient Outcomes
Drug Channels
Eli Lilly's Earnings
In the Pipeline
The Choice
In the Pipeline
Drug Channels News Roundup, October 2024: Humira Price War Update, PA vs. Providers, IRA vs. Physicians, My AI Podcast, New DCI Jobs, and Dr. G on Copayments
Drug Channels
GLP-1 For Everything
In the Pipeline
No More Delays: Accelerating Therapy Starts by Embedding Hub Services in Provider Workflows
Drug Channels
A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels

Latest Jobs

Pharmaceutical Sales Customer Engagement- Phoenix, AZ
Phoenix, Arizona,
Otsuka
Account Manager-Queens West, NY-Ophthalmics
Rego Park, New York, 11374
Sun Pharmaceutical Industries, Inc.
Account Manager-Queens West, NY-Ophthalmics
East Orange, New Jersey, 07017
Sun Pharmaceutical Industries, Inc.
Pharmaceutical Sales Customer Engagement - San Diego S, CA
San Diego, California,
Otsuka
Pharmaceutical Sales Customer Engagement - Thousand Oaks, CA
Thousand Oaks, California,
Otsuka
Pharmaceutical Sales Customer Engagement - Atlanta East, GA
Atlanta, Georgia,
Otsuka
Pharmaceutical Sales Customer Engagement - Eugene, OR
Eugene, Oregon,
Otsuka
Pharmaceutical Sales Customer Engagement - Portland E, OR
Portland, Oregon,
Otsuka
Psychiatry Account Manager - Greenville West, SC
Greenville, South Carolina, US
Lundbeck
Account Manager-Queens West, NY-Ophthalmics
Passaic, New Jersey, 07055
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information